Biallelic variants in TUBGCP6 result in microcephaly and chorioretinopathy 1: Report of four cases and a literature review.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
07 2023
Historique:
revised: 23 03 2023
received: 17 01 2023
accepted: 27 03 2023
medline: 8 6 2023
pubmed: 10 4 2023
entrez: 9 4 2023
Statut: ppublish

Résumé

Autosomal recessive microcephaly and chorioretinopathy-1 (MCCRP1) is a rare Mendelian disorder resulting from biallelic loss of function variants in Tubulin-Gamma Complex Associated Protein 6 (TUBGCP6, MIM#610053). Clinical features of this disorder include microcephaly, cognitive impairment, dysmorphic features, and variable ophthalmological anomalies including chorioretinopathy. Microcephaly can be recognized prenatally and visual impairment becomes evident during the first year of life. The clinical presentation resembles the findings in some acquired conditions such as congenital toxoplasmosis and cytomegalovirus infections; thus, it is important to recognize and diagnose this syndrome in view of its impact on patient health management and familial reproductive plans. To date, only seven molecularly confirmed patients from five unrelated families have been reported. We report an additional four unrelated patients with TUBGCP6 variants including one prenatal diagnosis and review the clinical phenotypes and genotypes of all the known cases. This report expands the molecular and phenotypic spectrum of TUBGCP6 and includes additional prenatal findings associated with MCCRP1.

Identifiants

pubmed: 37031378
doi: 10.1002/ajmg.a.63203
doi:

Substances chimiques

TUBGCP6 protein, human 0
Microtubule-Associated Proteins 0

Types de publication

Review Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1935-1941

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Amendola, L. M., Jarvik, G. P., Leo, M. C., McLaughlin, H. M., Akkari, Y., Amaral, M. D., Berg, J. S., Biswas, S., Bowling, K. M., Conlin, L. K., Cooper, G. M., Dorschner, M. O., Dulik, M. C., Ghazani, A. A., Ghosh, R., Green, R. C., Hart, R., Horton, C., Johnston, J. J., … Rehm, H. L. (2016). Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. American Journal of Human Genetics, 99(1), 247. https://doi.org/10.1016/j.ajhg.2016.06.001
Bahtz, R., Seidler, J., Arnold, M., Haselmann-Weiss, U., Antony, C., Lehmann, W. D., & Hoffmann, I. (2012). GCP6 is a substrate of Plk4 and required for centriole duplication. Journal of Cell Science, 125(Pt 2), 486-496. https://doi.org/10.1242/jcs.093930
Cox, D. M., & Butler, M. G. (2015). The 15q11.2 BP1-BP2 microdeletion syndrome: A review. International Journal of Molecular Sciences, 16(2), 4068-4082. https://doi.org/10.3390/ijms16024068
Dammermann, A., Desai, A., & Oegema, K. (2003). The minus end in sight. Current Biology, 13(15), R614-R624. https://doi.org/10.1016/s0960-9822(03)00530-x
Fowler, A., Mahamdallie, S., Ruark, E., Seal, S., Ramsay, E., Clarke, M., Uddin, I., Wylie, H., Strydom, A., Lunter, G., & Rahman, N. (2016). Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN. Wellcome Open Res, 1, 20. https://doi.org/10.12688/wellcomeopenres.10069.1
Fromer, M., Moran, J. L., Chambert, K., Banks, E., Bergen, S. E., Ruderfer, D. M., Handsaker, R. E., McCarroll, S. A., O'Donovan, M. C., Owen, M. J., Kirov, G., Sullivan, P. F., Hultman, C. M., Sklar, P., & Purcell, S. M. (2012). Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American Journal of Human Genetics, 91(4), 597-607. https://doi.org/10.1016/j.ajhg.2012.08.005
Ganapathi, M., Thomas-Wilson, A., Buchovecky, C., Dharmadhikari, A., Barua, S., Lee, W., Ruan, M. Z. C., Soucy, M., Ragi, S., Tanaka, J., Clark, L. N., Naini, A. B., Liao, J., Mansukhani, M., Tsang, S., & Jobanputra, V. (2022). Clinical exome sequencing for inherited retinal degenerations at a tertiary care center. Scientific Reports, 12(1), 9358. https://doi.org/10.1038/s41598-022-13026-2
Hull, S., Arno, G., Ostergaard, P., Pontikos, N., Robson, A. G., Webster, A. R., Hogg, C. R., Wright, G. A., Henderson, R. H. H., Martin, C. A., Jackson, A. P., Mansour, S., Moore, A. T., & Michaelides, M. (2019). Clinical and molecular characterization of familial exudative vitreoretinopathy associated with microcephaly. American Journal of Ophthalmology, 207, 87-98. https://doi.org/10.1016/j.ajo.2019.05.001
Karbassi, I., Maston, G. A., Love, A., DiVincenzo, C., Braastad, C. D., Elzinga, C. D., Bright, A. R., Previte, D., Zhang, K., Rowland, C. M., McCarthy, M., Lapierre, J. L., Dubois, F., Medeiros, K. A., Batish, S. D., Jones, J., Liaquat, K., Hoffman, C. A., Jaremko, M., … Higgins, J. J. (2016). A standardized DNA variant scoring system for pathogenicity assessments in Mendelian disorders. Human Mutation, 37(1), 127-134. https://doi.org/10.1002/humu.22918
Martin, C. A., Ahmad, I., Klingseisen, A., Hussain, M. S., Bicknell, L. S., Leitch, A., Nürnberg, G., Toliat, M. R., Murray, J. E., Hunt, D., Khan, F., Ali, Z., Tinschert, S., Ding, J., Keith, C., Harley, M. E., Heyn, P., Müller, R., Hoffmann, I., … Jackson, A. P. (2014). Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy. Nature Genetics, 46(12), 1283-1292. https://doi.org/10.1038/ng.3122
McKusick, V. A., Stauffer, M., Knox, D. L., & Clark, D. B. (1966). Chorioretinopathy with hereditary microcephaly. Archives of Ophthalmology, 75(5), 597-600. https://doi.org/10.1001/archopht.1966.00970050599003
Murphy, S. M., Preble, A. M., Patel, U. K., O'Connell, K. L., Dias, D. P., Moritz, M., Agard, D., Stults, J. T., & Stearns, T. (2001). GCP5 and GCP6: Two new members of the human gamma-tubulin complex. Molecular Biology of the Cell, 12(11), 3340-3352. https://doi.org/10.1091/mbc.12.11.3340
Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y. Y., Kobayashi, Y., Patil, N., Thusberg, J., Westbrook, M., The Invitae Clinical Genomics Group, & Topper, S. (2017). Sherloc: A comprehensive refinement of the ACMG-AMP variant classification criteria. Genetics in Medicine, 19(10), 1105-1117. https://doi.org/10.1038/gim.2017.37
Oakley, B. R., Paolillo, V., & Zheng, Y. (2015). Gamma-tubulin complexes in microtubule nucleation and beyond. Molecular Biology of the Cell, 26(17), 2957-2962. https://doi.org/10.1091/mbc.E14-11-1514
Puffenberger, E. G., Jinks, R. N., Sougnez, C., Cibulskis, K., Willert, R. A., Achilly, N. P., Cassidy, R. P., Fiorentini, C. J., Heiken, K. F., Lawrence, J. J., Mahoney, M. H., Miller, C. J., Nair, D. T., Politi, K. A., Worcester, K. N., Setton, R. A., DiPiazza, R., Sherman, E. A., Eastman, J. T., … Strauss, K. A. (2012). Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One, 7(1), e28936. https://doi.org/10.1371/journal.pone.0028936
Retterer, K., Juusola, J., Cho, M. T., Vitazka, P., Millan, F., Gibellini, F., Vertino-Bell, A., Smaoui, N., Neidich, J., Monaghan, K. G., McKnight, D., Bai, R., Suchy, S., Friedman, B., Tahiliani, J., Pineda-Alvarez, D., Richard, G., Brandt, T., Haverfield, E., … Bale, S. (2016). Clinical application of whole-exome sequencing across clinical indications. Genetics in Medicine, 18(7), 696-704. https://doi.org/10.1038/gim.2015.148
Richards, S., Aziz, N., Bale, S., Bick, D., das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Scheidecker, S., Etard, C., Haren, L., Stoetzel, C., Hull, S., Arno, G., Plagnol, V., Drunat, S., Passemard, S., Toutain, A., Obringer, C., Koob, M., Geoffroy, V., Marion, V., Strähle, U., Ostergaard, P., Verloes, A., Merdes, A., Moore, A. T., & Dollfus, H. (2015). Mutations in TUBGCP4 alter microtubule organization via the gamma-tubulin ring complex in autosomal-recessive microcephaly with chorioretinopathy. American Journal of Human Genetics, 96(4), 666-674. https://doi.org/10.1016/j.ajhg.2015.02.011
Strande, N. T., Riggs, E. R., Buchanan, A. H., Ceyhan-Birsoy, O., DiStefano, M., Dwight, S. S., Goldstein, J., Ghosh, R., Seifert, B. A., Sneddon, T. P., Wright, M. W., Milko, L. V., Cherry, J. M., Giovanni, M. A., Murray, M. F., O'Daniel, J. M., Ramos, E. M., Santani, A. B., Scott, A. F., … Berg, J. S. (2017). Evaluating the clinical validity of gene-disease associations: An evidence-based framework developed by the clinical genome resource. American Journal of Human Genetics, 100(6), 895-906. https://doi.org/10.1016/j.ajhg.2017.04.015
Sundercombe, S. L., Berbic, M., Evans, C. A., Cliffe, C., Elakis, G., Temple, S. E. L., Selvanathan, A., Ewans, L., Quayum, N., Nixon, C. Y., Dias, K. R., Lang, S., Richards, A., Goh, S., Wilson, M., Mowat, D., Sachdev, R., Sandaradura, S., Walsh, M., … Roscioli, T. (2021). Clinically responsive genomic analysis pipelines: Elements to improve detection rate and efficiency. The Journal of Molecular Diagnostics, 23(7), 894-905. https://doi.org/10.1016/j.jmoldx.2021.04.007
Wang, Y., Lichter-Konecki, U., Anyane-Yeboa, K., Shaw, J. E., Lu, J. T., Östlund, C., Shin, J. Y., Clark, L. N., Gundersen, G. G., Nagy, P. L., & Worman, H. J. (2016). A mutation abolishing the ZMPSTE24 cleavage site in prelamin a causes a progeroid disorder. Journal of Cell Science, 129(10), 1975-1980. https://doi.org/10.1242/jcs.187302

Auteurs

Amanda Thomas-Wilson (A)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

John P Schacht (JP)

Department of Pediatrics, Division of Clinical Genetics, Columbia University Irving Medical Center, New York, New York, USA.

David Chitayat (D)

Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Susan Blaser (S)

Department of Diagnostic Imaging, Division of Pediatric Neuroradiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Francis Jeshira Reynoso Santos (FJR)

Department of Clinical Genetics, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.

Kimberly Glaser (K)

Department of Clinical Genetics, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.

Alesky Caffo (A)

Department of Clinical Genetics, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.

Ingrid M Wentzensen (IM)

GeneDx, Gaithersburg, Maryland, USA.

Lindsay B Henderson (LB)

GeneDx, Gaithersburg, Maryland, USA.

Futao Zhang (F)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Ying Zhu (Y)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Ellen Di Corleto (E)

Maternal Fetal Medicine Unit, Gold Coast University Hospital, Gold Coast, Queensland, Australia.

Fabricio da Silva Costa (F)

Maternal Fetal Medicine Unit, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.

Rebecca Vink (R)

Neuroscience Research Australia (NeuRA), Sydney, New South Wales, Australia.
Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.

Ebba Alkhunaizi (E)

Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.

Laura Russell (L)

Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.

Michael F Buckley (MF)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Tony Roscioli (T)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Neuroscience Research Australia (NeuRA), Sydney, New South Wales, Australia.
Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Elaine Maria Pereira (EM)

Department of Pediatrics, Division of Clinical Genetics, Columbia University Irving Medical Center, New York, New York, USA.

Mythily Ganapathi (M)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH